(2E)-N-(3,4-DIHYDRO-4-OXO-7-(((3S)-TETRAHYDRO-3-FURANYL)OXY)-6-QUINAZOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE

UNII:	8P652B3QLZ
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₈H₂₂N₄O₄
Preferred Substance Name:	(2E)-N-(3,4-DIHYDRO-4-OXO-7-(((3S)-TETRAHYDRO-3-FURANYL)OXY)-6-QUINAZOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE
InChIKey:	GSUSIQVMAQBROU-PCAWENJQSA-N
GSRS Full Record:	8P652B3QLZ i

1456696-14-2
(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
(S,E)-4-(dimethylamino)-N-(4-hydroxy-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide
2-Butenamide, N-[3,4-dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-
Afatinib impurity J

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

(2E)-N-(3,4-DIHYDRO-4-OXO-7-(((3S)-TETRAHYDRO-3-FURANYL)OXY)-6-QUINAZOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE

Synonyms and Mappings

Resources